Nature-based solutions like restoring mangroves, and hybrid solutions, protect vulnerable shorelines. However, they need careful planning to be effective. A new GIS-based tool, combined with varied experts’ input, has identified the best shoreline stabilization methods for the Florida Keys. Findings show that about 8% of coastline is suitable for nature-based or hybrid solutions, while 25.1% is unsuitable, and 67% is already vegetated or naturally protected. The tool integrates data on shoreline types, environmental factors and wave exposure to guide decisions on shoreline protection.

A breakthrough in biomedical research is reshaping the way scientists study human biology. Assembloids—advanced 3D tissue models that integrate multiple organoids or specialized cell types—are unlocking new dimensions in developmental biology, disease modeling, and drug discovery by more closely mimicking the complex cellular interactions within human tissues. A recent review categorizes assembloids into four key assembly strategies—multi-region, multi-lineage, multi-gradient, and multi-layer—each designed to better simulate complex biological processes with unprecedented accuracy. By bridging the gap between simplified organoids and the intricate architecture of human tissues, assembloids are poised to transform our understanding of health and disease.

A significant amount of the milk used in a popular cooking cheese can be substituted with plants, all while maintaining its taste and texture. Researchers from the University of Copenhagen have demonstrated this by creating a hybrid version of paneer, a popular South Asian cheese, with twenty-five percent pea protein. The result is a solid step towards more sustainable dairy products with nutritional benefits.

New active ingredients such as antibodies are usually tested individually in laboratory animals. Researchers at UZH have now developed a technology that can be used to test around 25 antibodies simultaneously in a single mouse. This should not only speed up the research and development pipeline for new drugs, but also hugely reduce the number of laboratory animals required.